Apellis Pharmaceuticals, Inc.
← Back to APLS Overview

Apellis Pharmaceuticals, Inc. (APLS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

67.05

Financial Fundamentals

APLSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-03-31-5.75
2014-06-30-5.75
2014-09-30-25.05
2014-12-31-23.38
2015-03-31-17.54
2015-06-30-17.54
2015-09-30-2.04
2015-12-31-7.79
2016-03-31-9.48
2016-06-30-9.48
2016-09-30-8.77
2016-12-31-9.48
2017-03-31-7.01
2017-06-30-5.24
2017-09-30-10.32
2017-12-31-15.07
2018-03-31-12.85
2018-06-30-9.02
2018-09-30-6.82
2018-12-31-5.07
2019-03-31-5.60
2019-06-30-5.68
2019-09-30-5.47
2019-12-31-4.97
2020-03-31-2.92
2020-06-30-5.20
2020-09-30-4.21
2020-12-3114.44
2021-03-31-4.62
2021-06-30-5.81
2021-09-30-3.61
2021-12-31-6.83
2022-03-31-8.95
2022-06-30-7.74
2022-09-30-9.76
2022-12-31-8.62
2023-03-31-10.57
2023-06-30-22.33
2023-09-30-8.13
2023-12-31-20.50
2024-03-31-27.64
2024-06-30-30.24
2024-09-30-15.67
2024-12-31-27.51
2025-03-31-7.39
2025-06-30-13.11
2025-09-303.31
2025-12-31-13.36
2026-03-3167.05

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.